Novartis | NOVN - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 72M 10M 2025-09
Almirall EUR 2.71M 580K 2025-12
AstraZeneca USD 85M 17M 2025-09
Autolus Therapeutics Ltd USD 6.14M 1.31M 2025-03
Bayer EUR 130M 38M 2025-09
Biogen USD 31.6M 700K 2025-09
Eli Lilly USD 65M 25M 2025-09
Fresenius Medical Care EUR 13.62M 5.54M 2025-12
Galapagos EUR 12.56M 4.66M 2025-03
Genmab DKK 25M 8M 2025-06
Gilead Sciences USD 88M 15M 2025-09
GlaxoSmithKline GBP 26M 24M 2025-09
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
J&J USD 2.12 0.17 2025-09
Merck EUR 27M 10M 2025-09
Merck USD 96M 27M 2025-09
Pfizer USD 0.62 156M 2025-09
Philips EUR 21M 2M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09